TW200822860A - Embalming mixture, preparation method therefor, and method of treating corpses with the embalming mixture - Google Patents

Embalming mixture, preparation method therefor, and method of treating corpses with the embalming mixture Download PDF

Info

Publication number
TW200822860A
TW200822860A TW96112673A TW96112673A TW200822860A TW 200822860 A TW200822860 A TW 200822860A TW 96112673 A TW96112673 A TW 96112673A TW 96112673 A TW96112673 A TW 96112673A TW 200822860 A TW200822860 A TW 200822860A
Authority
TW
Taiwan
Prior art keywords
mixture
embalming
change
antiseptic
alcohol
Prior art date
Application number
TW96112673A
Other languages
Chinese (zh)
Inventor
Tetsuji Kondo
Original Assignee
Tetsuji Kondo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetsuji Kondo filed Critical Tetsuji Kondo
Publication of TW200822860A publication Critical patent/TW200822860A/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention is to obtain a mixture for embalming a corpse and to provide a method for preparing the same and a method for applying the embalming mixture to a corpse and treating the corpse therewith. The mixture for embalming a corpse is obtained and the method for preparing the same and an application thereof are provided. The mixture for embalming a corpse comprises mainly 0.15-10% in a volume ratio of an isothiazoline ketone compound, 5-30% of a dihydric alcohol, 3-20% of glycerin, 0-15% of an alcohol, 5-50% of n-hexyl alcohol, 1-15% of dimethyl sulfoxide, 1-18% of a plant extract and 0-30% of pure water and 0.1-15% in a weight ratio of a nipagin ester or 1-15% of urotropine. An antiseptic is injected into the aortic arch to exert a rapid and effective antiseptic action on a corpse. The embalming mixture has wide antimicrobial properties, has a high action rate, excellent compatibility with an enzyme and low toxicity and is suitable for embalming a corpse in an environment, especially, humidity, etc.

Description

200822860 九、發明說明: 【發明所屬之技術領域】 本發明乃關於防腐技術之領域,具體而言,係關於遺體防 腐混合物及其調製方法與對遺體施用防腐混合物之處理方 法0 【先前技術】 已往,已有中國發明ZL01132050B所揭示之「防腐劑」 或中國發明申請CN200410053606· 8所揭示之「短期間之遺體 防腐巧之遺體防腐混合物」及中國發明申請CN2〇〇41〇〇66612. 7 所揭示之「長期間之遺體防腐遺體防腐混合物」之種種嘗試 公開。 按此等防腐劑係設計為分別從不同之角度來對遺體施以 防腐處理,以應各種不同之習俗、自然環境及設備條件之要 求’而達到基本上之防腐效果。 ^刚述防腐劑及利用既有習知技術之遺體防腐劑皆使用過 氧化物(peroxide)為主。過氧化物雖具有良好之防腐作用, 但在防腐之㈤時必紐线體、瓦斯,往糾起遺體之膨脹 或扭曲變形,加深了死者家屬心理上不甘與痛苦。 八-此外i在多濕之環境裡,上述防腐劑之防腐效果並不十 分t人滿意。為改善此類防腐劑混合物之性能提高及適應各 種環境及地區之防腐之要求,經本發明人潛心研究,反覆試 驗,遂完成本發明之新穎遺體防腐混合物。 +本發明欲解決之技術上問題為,提供一種更能保證遺體 生,同日守犯適應各種環境之新穎有效之遺體防腐混合 ,,,明也提供此遺體防腐混合物之調製方法及使用此防 腐混合物以處理遺體之方法。 5 200822860 【發明内容】 本發明提供之新穎之遺體防腐混合物係由: 谷積比率0· 15〜15%之異嗔哇琳酮(is〇thiazoline ketone) 類化合物,5〜30%之二元醇,3〜20%之甘油,0〜15%之醇, 5〜50%之正已醇’ 1〜15%之二甲亞石風(dimethyl sulfoxide) 1〜18%之植物萃取物,〇〜30%之淨水,及重量比率〇·丨〜]^% 之尼泊金酯(Nipagin ester)或1〜15%之烏洛托品 (urotrop in)混合而構成。 本發明所述之植物萃取物使用原料為紫丁香、高良薑、 肉桂、山椒、牡丹皮,經醇液萃取之萃取物,各原料之最佳 配合比以重量比計為紫丁香、高良薑、肉桂、山椒、牡丹皮= (1 〜2) ·· (1 〜3) : (〇·5〜1) : (2〜4) : (1 〜4)。 本發明所述之異噻唑琳酮類化合物係選自:由2—曱基一4一 異嗔哇琳-3-酮、2-曱基-3(2Η)-異噻唑啉酮、2-甲基-3(H)-異噻 唑啉酮、1,2-苯並異噻唑啉—3-酮及5-氯-2_甲基-4-異噻唑啉 - 3-S同所構成之群中最適合之一種或多種化合物。、 、又,本發明所述之二元醇係選自乙二醇及丙二醇中之一 種或其一種之混合物中最適用者。 必要時,本發明之防腐混合物中尚可添加適量之 以適應環境之需要。 本發明為適應防腐對象之種種要求及防腐操作,開發出 三種類之可個別單獨使用亦可互相組合使用之優良之< 法,此等調製方法係由下列配方構成。 χ Α液調製方法: 將,積比# 〇· 15〜15%之異射細類化合物,5〜2〇%之二 兀醇,3〜15%之甘油,5〜30%之正已醇,1〜15%之二甲亞 1〜18%之植物萃取物,5〜3〇%之淨水,及重量比率丨〜/ 烏洛托品混合調製而成。 0 B液調製方法·· 6 200822860 私伽触合物,5〜2.二元醇, 之淨水,及她⑷〜歐烏洛Γ 物之料,上賴腐混合 ⑴lUii率,搗碎或磨碎植物之紫丁香、高良薑、 山叔二桂皮及牡丹皮取得⑽公克之粉碎物,“於 該浸十四小時後,用活性侧並脫色 ⑵烏洛托品(__)溶解於淨水中以 付其洛液,或將所定配合比之尼泊金 溶解於醇巾赌其歸備細; g n ester) (3)依所定配合比,將異嗟唾啦酮類化合物添加於 並加以擾拌之後,依序將甘油及正已 =,於每加:種物質時加以授掉20至40分^·ς^ 此合液紐暫靜置之後,再添加二甲亞_續授摔; ⑷將依=定配合比調製之上述⑴及⑵之準 ^腐合^物經均娜之後,靜請小時而製賴 遺體技術為,公開上述防腐混合物對 由於本發明之遺體混合物之活性成分主要是對經 鹽及異多坐伽類化合物’此二種成分能抑止細胞之生長及 促進細胞之壞死(apoptosis)—點在原理上相同。上又 觸細胞膜數分鐘後,立即滲透進人助,而能抑制細胞= 性。丙_酸去氩酶’ 戊二酸去氫酶、琥珀酸去 NADH去氫酶均為促進細胞代謝之循環之關鍵酵素。 更者’本發明之防腐混合物能作用於上述四種不同之酵 7 200822860 之Γ及巨大分子之合成,故可迅速降 維持日當ί。由於能量系統崩潰,細胞無法合成其 二iifU'tf化合物,最後能達成防腐之目的。 沒人物且;^ 均具有—部分循環,唯本發明之防腐 〜物具有_關非常廣泛,且目的之 =生:變微生物之耐藥性。隨著循ί=ί, ^月匕里及曰成酵素專生物活性物質之生產能力叁产,丨 下降,因而進-步提高防腐效果。 貝之生H、劇 ώ ίΐϊ,進入遺體之後,能在_環境下凝固細菌之蛋 白,而直接觀細g之同時,也會凝固表皮與真皮間之結入 步形成障壁’以防止已腐敗之氣體與液體外漏, 並遮斷腐敗之發展而有效防止表皮之祕,因而也間接 除臭效果。又因表皮會乾燥,可減少來自外界之 霉菌之生長。 闽丨又八汉 η本發明為應種種防腐對象之要求及防腐操作之必要,選 擇最適合之上述Α及Β二種調合液。a、Β之調合液可用穿 刺注射進入遺體之主動脈,而達成全身防腐作用。A、B調 合液可個別單獨使用,亦可合併使用。A、B調合液如係合 併使用,其防腐效果最高,在室溫下放置最少也能保存遺& 25日長。 在一般狀況,A調合液做為基本調合液,而將B調合液 與A調合液合併使用。a、B調合液之使用量,可視遺體之 保存日數及腐敗程度而決定。A調合液對每一遺體至少應使 用500毫升(ml),B調合液之使用量亦視遺體之保存日&及 腐敗程度而決定。發明人建議如下: 遺體之保存如在15日以内時,可注入B調合液約15〇〇 毫升。保存20日時,注入B調合液約2500毫升。保存25日 日才’注入B调合液約3000毫升。如欲保存25日以上時,應 注入注入B調合液約3500毫升。遺體之腐敗情形如明顯時, 200822860 B調合液之注入量可相應增加500〜1000毫升。 A、B調合液係藉穿刺大動脈弓將防腐液注入以行全身 防腐,有別於向來慣用之執刀以將防腐液注入動脈内之傳統 方法,既無必要開刀形成切口,且可獲得最有效之全身防腐 效果,喪中家族也容易接受。 •本發明藉穿刺將防腐液注入大動脈弓之具體操作方法如 下: 1·動脈弓之部分解剖與表面投影 4刀解4 ·大動脈弓係自大動脈向上延伸,且位於胸骨之 ;^部、氣管之前面;左邊為肺動脈,右邊為避 靜脈。 1 表面投影:動脈弓係在胸骨之中央線、第二、三肋骨之間, 而不超過胸骨之左緣。大動脈之解剖位置固i, 齡、性別、體型、體重、疾病等之因 2. 注射點:胸骨上方漥部之底部。 3. 注射角度:對皮膚25〜45度角 4· ί木 度··約10〜12公分 5. 打針之感覺=射軟6〜7公分時 感’而將針注入更深時,突有4:見:, 6. 注入成功之觀;後即無手感反應, 2)2旦注3::外:確入’但抽不出來。 血液之顏色及量_:心官疋動脈或靜脈,藉觀察 伽注入氣管之情形獻 但只有少量可被抽出,造主入量特別多, 7·注入速度··注人之流逮最“ 出防腐液。 200822860 根據本發明,將防腐混合物A、B調合液注入大動脈弓 即可加速防腐液之流速,均勻遍佈遺體全身,遮斷腐敗並抑 制自身分解及溶解’而提高防腐效率。當有因腐敗而生之氣 體及液體漏於表皮層下時,會生成張力性之氣泡與水泡,而 極容易造成表皮剝落、腫脹、變形、發黑並發出惡臭。然而, 本發明A、B调合液能有效抑止細菌在表皮生長,並可固定 真皮與表皮之麟,因此,可防止表皮因鬆弛而娜 兩種調合液’可提高遺體之防腐效果, 完整形ί。、、就發生及組織之軟化,因*可轉遺體之 驗,進行關連之細菌抑制之試 1·進行试驗之菌種: 哮酒酵母菌、黑色麴菌、黃色麴菌 宛氏擬青梅_、球毛殼黴8、綠色\=囷、,青黴菌、 菌、黃色葡萄球菌、鏈球菌、枯草、鏡葉芽枝黴 假單胞桿菌、巨大芽胞桿菌。 、大腸桿菌、螢光 2·試驗條件: 細菌在36 ± it,黴菌及酵母 時間.細菌與酵母菌為24小時,,28 ± ic。 3.試驗方法:平碟抑菌輪法 ”’為72小時。 4·所用試液 ίί明防腐混合物之A調合液 〇· · 防腐劑之關種做為_。 200822860 表1 酵麵' 11 細菌 :試液 平均抑麵之 直徑(cm) 平縣菌輸之 直徑(cm) __菌輪之 直徑(cm) 本發明防iS合 物之A調合液 Ώ : 6.15 : 過氧化物類 4.35 342 3,60 戊二醛類 4.05 3, 1J55 氯酚類 2J5 2.00 53S S制 4++ 4+f (表內之+++係以肉眼觀察之在培養平板滿視野上成長之供試驗用細菌之成長狀況) 由上述試驗證實本發明之防腐混合物具有廣泛之抗菌 性、作用速度迅速、與酵素有良好之取代作用及不受與酵素 或抗體之關聯性反應之影響。使用A調合液處理2〇〇具遺體 之防腐(其中1〇具在攝氏3〇〜35艺,濕度7〇〜93%之g境下 施行)之結果,經3〜10天之時點,遺體之形體保持完整猶如 在睡眠中,肢體柔軟,無臭且胸腹部未見有膨脹。 本發明之防腐混合物在pH值2〜9之範圍内皆有殺菌作 用,且即使在室溫下放置一年,其活性成分基本上不變。由 於本發明之防腐混合物在防腐之過程中不產生氣體,毒性很 低。尤其是適用於在多濕環境下之遺體之防腐。 【實施方式】 以下就本發明之具體實施方式說明·· 〔實施例1〕 A調合液之調製·· 200822860 2-曱基-3(2H)-異嗟tr坐琳酮 40ml 乙二醇 160ml 甘油 100ml 正已醇 220ml 烏洛托品 70g 二甲亞颯 50ml 植物萃取物 60ml 清淨水 200ml200822860 IX. Description of the invention: [Technical field to which the invention pertains] The present invention relates to the field of anticorrosion technology, and more particularly to a method for treating a residue antiseptic mixture and a method for preparing the same, and a method for applying an antiseptic mixture to a remains. [Prior Art] The "preservative" disclosed in Chinese invention ZL01132050B or the "anti-corrosion mixture of the body of anti-corrosion in short period of time" disclosed in Chinese invention application CN200410053606·8 and the Chinese invention application CN2〇〇41〇〇66612. Various attempts to disclose the "preservative mixture of preserved remains of long-term remains". According to these preservatives, the antiseptic treatment is applied to the remains from different angles to achieve a basic antiseptic effect in response to various customs, natural environments and equipment conditions. The preservatives and the preservatives using the prior art techniques are mainly peroxides. Although peroxide has a good antiseptic effect, in the case of anti-corrosion (five), the neon body and gas will expand or distort the body, which will deepen the psychological unwillingness and suffering of the deceased's family. Eight - In addition, in the wet environment, the preservative effect of the above preservatives is not satisfactory. In order to improve the performance improvement of such a preservative mixture and to meet the requirements of anticorrosion in various environments and regions, the inventors have intensively studied and repeated tests to complete the novel antiseptic mixture of the present invention. + The technical problem to be solved by the present invention is to provide a novel and effective antiseptic mixture of the remains which can better ensure the remains of the body and adapt to various environments on the same day, and also provide a method for preparing the antiseptic mixture of the remains and using the antiseptic mixture. To deal with the remains. 5 200822860 SUMMARY OF THE INVENTION The novel antiseptic mixture provided by the present invention is composed of: a compound having a grain ratio of 0·15 to 15% of is〇thiazoline ketone, and a diol of 5 to 30%. 3~20% glycerol, 0~15% alcohol, 5~50% hexanol' 1~15% dimethyl sulfoxide 1~18% plant extract, 〇~30 % of purified water and a weight ratio of pa·丨~]^% of Nipagin ester or 1 to 15% of urotropin are mixed. The plant extract of the present invention uses the raw materials of lilac, galangal, cinnamon, pepper, and peony bark, and the extract is extracted by alcohol liquid, and the optimum mixture ratio of each raw material is lilac and galangal in weight ratio. Cinnamon, pepper, peony bark = (1 ~ 2) · · (1 ~ 3) : (〇 · 5 ~ 1) : (2 ~ 4) : (1 ~ 4). The isothiazolone compound of the present invention is selected from the group consisting of 2-mercapto-4-isoxanthene-3-one, 2-mercapto-3(2Η)-isothiazolone, 2-methyl a group consisting of a group of 3-(H)-isothiazolinone, 1,2-benzisothiazolin-3-one and 5-chloro-2-methyl-4-isothiazoline-3-S The most suitable compound or compounds. Further, the diol of the present invention is preferably selected from the group consisting of ethylene glycol and propylene glycol or a mixture thereof. If necessary, an appropriate amount of the antiseptic mixture of the present invention may be added to suit the environment. The present invention has developed three excellent types of methods which can be used individually or in combination with one another in order to meet the various requirements of anti-corrosion objects and anti-corrosion operations. These preparation methods are composed of the following formulations. χ Α 调制 调制 调制 : : : : : : : : : : : : : : : : : : : : : : : : 1~15% of dimethyl amide 1~18% of plant extract, 5~3〇% of purified water, and weight ratio 丨~/ urotropine mixed preparation. 0 B liquid preparation method·· 6 200822860 Private gamma conjugate, 5~2. diol, purified water, and her (4) ~ ouoluo material, mixed with sulphur (1) lUii rate, mashed or ground (10) grams of crushed material of cloves, galangal, sage, and peony bark of crushed plants, "after 14 hours of immersion, use active side and discolor (2) urotropine (__) dissolved in purified water In order to pay for the Lok Loi, or to dissolve the nibgin in the blending ratio, it is fine; gn ester) (3) Add and irritate the isoindole ketones according to the specified mixing ratio After that, the glycerin and the positive ginseng will be given in the order of 20 to 40 minutes for each addition of the substance. ^ ς ^ After the liquid mixture is temporarily placed, add the dimethyl _ continuation drop; (4) According to the above formula (1) and (2), the above-mentioned (1) and (2) quasi-corrosion products are subjected to the stagnation method, and the stagnation technique is used for the hour, and the above-mentioned antiseptic mixture is disclosed. The active ingredient of the mixture of the remains of the present invention is mainly Salt and heteropolysodium conjugates' These two components can inhibit cell growth and promote cell necrosis (apoptosis) - The point is the same in principle. After touching the cell membrane for a few minutes, it immediately penetrates into the human help, and can inhibit the cell = sex. Propionate dehydrogenase glutarate dehydrogenase, succinic acid de-NADH dehydrogenase The key enzyme to promote the cycle of cell metabolism. Moreover, the antiseptic mixture of the present invention can act on the synthesis of the above four different yeasts 7 200822860 and the synthesis of huge molecules, so that it can quickly fall to maintain the Japanese ί. Due to the collapse of the energy system The cells can not synthesize their two iifU'tf compounds, and finally achieve the purpose of antiseptic. Nobody and; ^ have - part of the cycle, only the antiseptic of the invention has a very wide range, and the purpose = raw: variable microorganisms The drug resistance. With the production capacity of 匕 = ^ ^ ^ ^ ^ 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵 酵After entering the body, it can coagulate the protein of the bacteria in the environment, and directly observe the fine g, it will also solidify the junction between the epidermis and the dermis to form a barrier to prevent the spoiled gas and liquid from leaking and blocking. Corruption It develops and effectively prevents the secret of the epidermis, and thus indirectly deodorizes the effect. Because the epidermis will be dry, it can reduce the growth of mold from the outside. 闽丨 八八汉 η This invention is necessary for various anti-corrosion objects and anti-corrosion operation Select the most suitable combination of the above-mentioned sputum and sputum. A, sputum blending solution can be injected into the aorta of the corpse by puncture, and achieve the whole body antiseptic effect. The A and B blending liquids can be used individually or in combination. If the combination of A and B is combined, it has the highest anti-corrosion effect. It can be stored at room temperature for at least 25 days. In general, A blending solution is used as the basic blending solution, while B blending solution is used. A blending solution is used in combination. The amount of a and B blending solution can be determined by the number of days of preservation and the degree of corruption. A blending solution should use at least 500 ml (ml) for each body. The amount of B blending solution is also determined by the date of storage and the degree of corruption of the remains. The inventor's suggestion is as follows: When the remains are kept within 15 days, about 15 ml of B blending solution can be injected. When stored for 20 days, inject about 2500 ml of B blending solution. Save on the 25th day of the 'injection of B blending solution about 3000 ml. If you want to keep it for more than 25 days, you should inject about 3500 ml of B blending solution. If the corruption of the remains is obvious, the injection volume of the 200822860 B blending solution can be increased by 500~1000 ml. The A and B blending fluids are injected into the aortic arch to inject the antiseptic solution for whole body preservation. It is different from the conventional method of using the conventionally used knife to inject the antiseptic solution into the artery. It is not necessary to open the incision and obtain the most effective one. The body's antiseptic effect is also easy to accept. The specific operation method of the invention for injecting the antiseptic solution into the aortic arch by the puncture is as follows: 1. Partial anatomy and surface projection of the arterial arch 4 knife solution 4 · The aortic arch system extends upward from the aorta and is located in the sternum; Front; the left side is the pulmonary artery, and the right side is the vein. 1 Surface projection: The arterial arch is between the central line of the sternum, between the second and third ribs, and does not exceed the left edge of the sternum. The anatomical location of the aorta is solid, age, sex, size, weight, disease, etc. 2. Injection point: the bottom of the sternum above the sternum. 3. Injection angle: 25 to 45 degree angle to the skin 4 · ί wood degree · about 10 to 12 cm 5. The feeling of injection = the feeling of soft 6~7 cm when the needle is injected deeper, the protrusion 4: See:, 6. The concept of successful injection; after the no-feel response, 2) 2 Dan Note 3:: Outside: Indeed into the 'but can not pump out. The color and quantity of blood _: the heart of the iliac artery or vein, by observing the situation of gamma injection into the trachea, but only a small amount can be extracted, the amount of the main input is particularly large, 7·injection speed·· Antiseptic solution. 200822860 According to the present invention, the antiseptic mixture A and B blending solution can be injected into the aortic arch to accelerate the flow rate of the antiseptic solution, uniformly spread throughout the body, block the spoilage and inhibit self-decomposition and dissolution, and improve the antiseptic efficiency. When the gas and liquid generated by the corruption leak under the epidermis, tension bubbles and blisters are formed, which are likely to cause peeling, swelling, deformation, blackening and foul odor. However, the A and B blending liquids of the present invention It can effectively inhibit the growth of bacteria in the epidermis, and can fix the lining of the dermis and the epidermis. Therefore, it can prevent the epidermis from relaxing and the two kinds of blending liquid can improve the antiseptic effect of the remains, the complete shape, the occurrence and the softening of the tissue. Because of the test of the transferable body, the test for the inhibition of the related bacteria 1. The strains to be tested: Rotary yeast, black sputum, yellow sputum, Wan's green _, ball hair Mildew 8, green \=囷,, Penicillium, bacteria, Staphylococcus aureus, Streptococcus, hay, Pseudomonas fuliginea, Bacillus megaterium. Escherichia coli, fluorescent 2. Test conditions: Bacteria at 36 ± it, mold and yeast time. Bacteria and yeast are 24 hours, 28 ± ic. 3. Test method: flat plate inhibition wheel method "' is 72 hours. 4. Test solution used ί 明 防 A mixture of anti-corrosion mixture 〇 · · Preservatives as a kind of _. 200822860 Table 1 Fermented noodles ' 11 Bacteria: Diameter of the average surface of the test solution (cm) Diameter of the flat fungus (cm) __ Diameter of the fungus wheel (cm) A blending liquid of the anti-iS compound of the present invention: 6.15: Peroxides 4.35 342 3,60 Glutaraldehyde 4.05 3, 1J55 Chlorophenols 2J5 2.00 53S S 4++ 4+f (+++ in the table is grown on the full field of view of the culture plate by naked eyes The growth condition of the test bacteria is confirmed by the above test. The antiseptic mixture of the present invention has broad antibacterial properties, rapid action speed, good substitution with enzymes, and no influence on the reaction with enzymes or antibodies. Use A to adjust the anti-corrosion of the body of the 2 utensils (1 of which is carried out in the range of 3〇~35 art in Celsius and 7〇~93% in humidity). After 3~10 days, the remains are The body remains intact as if it were in sleep, the limbs are soft, odorless and there is no swelling in the chest and abdomen. The preservative mixture of the present invention has a bactericidal action in the range of pH 2 to 9, and its active ingredient remains substantially unchanged even after being left at room temperature for one year. Since the anticorrosive mixture of the present invention does not generate gas during the preservation process, the toxicity is low. Especially suitable for the preservation of remains in a humid environment. [Embodiment] Hereinafter, a description will be given of a specific embodiment of the present invention. [Example 1] Modulation of A blending solution·· 200822860 2-mercapto-3(2H)-isoindole tralone 40 ml ethylene glycol 160 ml glycerin 100ml regular alcohol 220ml urotropine 70g dimethyl hydrazine 50ml plant extract 60ml clean water 200ml

(1) i取紫丁香:高良蠢·山椒·肉桂皮·牡丹皮= 1 : 1 ·· 1 : 2 : 1(以重量比計),並將此等物質搗碎或磨 碎後,取用100公克浸泡於100毫升(ml)之醇中24小 時,隨之將此浸泡液經活性碳過濾並脫色以供其後使 用0 (2)依照配合比取80公克之烏洛托品溶解於2〇〇毫升之清 淨水中以供使用。 (3)依照配合比將異噻唑啉酮類化合物加入乙二醇中並 撥拌之後’接著依順序添加以甘油及正已醇,=六 加-種物質時應麟2G〜4G分鐘。將此混合靜=、 刻之後,再添加二甲亞颯,並繼續攪拌, 二 自(1)之植物萃取物70毫升及得自(2)之準 將付 述混合液中並攪拌均勻之後’靜置2c入上 發明之A調合液。 4 /吩’即可得本 〔實施例2〕 A調合液之調製: 50ml 16〇ml 7〇ml 200ml 8〇g 甲基-4-異嗓唾琳-3-酉同 乙二醇 甘油 正已醇 烏洛托品 12 200822860 一曱亞硬 50ml 植物萃取物 70ml 清淨水 200ml (1)量取紫丁香: 高良薑··山椒:肉桂皮:牡丹皮= 1:1:1: X · i · i ·厶· 1、从里里,亚;i牙开柳貝瑪碎或磨 碎後,取用100公克浸泡於100毫升(ml)之醇中24小 時,隨之將此浸泡液經活性碳過濾並脫色以供其後使 用。 ’、 (2) 依照配合比取80公克之烏洛托品溶解於2〇〇奎弁 淨水中以供使用。 笔升之α (3) 依照配合比將異噻唑啉_類化合物加入乙二 猜之後,接著依順序添加以甘油及正。 狀後,再添加二甲亞靜置 自⑴之植物萃取物70毫升及得自⑵=將知 述混合液中並攪拌均句之後,缚 備液加入上 發明之Α調合液。 θ 4小時,即可得本 〔實施例3〕 A調合液之調製: 2-甲基-3(H)-異噻唑啉酮 丙二醇 甘油 正已醇 烏洛托品 二曱亞颯 植物萃取物 清淨水 30ml 120ml 80ml 220ml 80g 調製方法與實施例1相同…〜本^ 肉桂皮:牡丹皮: 2 : 1 : 2 : 8〇ml 60ml 250ml 了香··高良薑:山椒: 13 200822860 〔實施例4〕 B調合液之調製: 2-曱基-3(2H)-異嗟峻嘛酮 60ml 丙二醇 150ml 甘油 100ml 正已醇 120ml 烏洛托品 120g 二甲亞颯 70ml 植物萃取物 120ml 清淨水 180ml 調製方法與實施例2相同,只是紫丁香:高良薑:山椒: 肉桂皮:牡丹皮二1 : 2 : 1 : 2 : 1(重量比)。 〔實施例5〕 A調合液之調製: 1,2-苯並異嗟嗤琳-3-酮 10ml 2-甲基-4-異隹嗤琳- 3-嗣 10ml 乙二醇 180ml 120ml 180ml 60g 90ml 130ml 180ml 甘油 正已醇 烏洛托品 二甲亞颯 植物萃取物 清淨水 調製方法與實施例1相同,只是紫丁香··高良薑:山椒: 肉桂皮:牡丹皮=2 : 3 : 1 : 2 : 4(重量比)。 〔實施例6〕 B調合液之調製: 40ml 25ml 1,2-苯並異嗟.坐琳-3-酉同 5-氯-2-曱基-4-異嗟σ坐琳-3-酮 14 200822860 乙二醇 90ml 125ml 250ml 110g 65ml 90ml 165ml 甘油 正已醇 烏洛托品 二曱亞礙 植物萃取物 清淨水 調製方法與實施例2相同,只是紫丁香··高良薑··山椒: 肉桂皮:牡丹皮=2 ·· 3 : 1 ·· 2 ·· 4(重量比)。 [實施例7 ] 〜川與員他例1汉貝娜π 4碉制而得之防腐混合物A、 用遺體浸浴之ί ’用毛巾擦乾全身,然後,先 用左射同抽取防腐混合物之Α液5〇〇毫井,蔣无 進人大動脈弓。接著,將防腐混合物匈骨 升/主入。所得之防腐絲如表2所载: ^ 2500 15 200822860 表2 登錄 番號 項目 例1 例2 例3 性別 男 男 女 年齡 69 72 80 體型 普通 瘦 胖 死亡日 2006/07/19 2006/07/28 2006/06/25 死亡原因 心腦血管 胃癌 心腦血管 保存方式 遺體床 遺體床 遺體床 保存溫度°0 28 28 28 保存濕度% 70 70 70 顏面顏色 青紫色 黃白色 青紫色 胸部 平 平 膨脹 腹部 膨服 略呈綠色 膨脹 水腫 輕度 無 顯著 屍斑 有 有 面積廣闊 剝皮情形 無 有 有 臭味 無 臭 微臭 (大動脈) 防腐液 A 液 500ml A 液 500ml A 液 500ml (大動脈) 防腐液 B 液 2500ml B 液 2500ml B 液 2500ml 第1曰 顏面之顏色如前無變化,腹 部平滑無臭,彷彿在安眠中 顏面蒼白,腹部平滑且柔 軟,無臭,彷彿在安眠中。 顏面之顏色如前無變化, 腹部平滑且柔軟,無臭, 彷彿在安眠中。 第2曰 無變化 無變化 無變化 第3曰 無變化 無變化 無變化 第4曰 胸腹平滑柔軟、無臭 胸腹平滑柔軟、無臭 胸腹平滑柔軟、無臭 16 200822860 第5曰 無變化 無變化 無變化 第6曰 無變化 無變化 無變化 第7曰 無變化 無變化 無變化 第8曰 無變化 無變化 無變化 第9曰 顏面及手指有若干乾燥,全 身之皮膚完全乾燥,無臭味。 無變化 無變化 第10曰 無變化 顏面及手指有若干乾燥, 全身之皮膚完全乾燥,無 臭味。 顏面如同前無變化,腹部 平滑柔軟,無臭,皮膚乾 燥,彷彿在睡眠中。 第‘11曰 無變化 無變化 無變化 第12曰 無變化 無變化 無變化 第13曰 無變化 無變化 無變化 第14曰 無變化 無變化 無變化 第15曰 顏面若干乾燥。 無變化 無變化 第16曰 無變化 無變化 腹部積氣而若干膨脹。 第17曰 無變化 上肢之背面側有水泡 有若干臭味 第18曰 無變化 下肢之背面側有水泡 同前 第19曰 無變化 顏面有若干乾燥 下肢之背面側有水泡 第20曰 無變化 無變化 顏面如同前無變化 第21曰 火葬 火葬 火葬 【圖式簡單說明】 無圖 【主要元件符號說明】 無 17(1) i take lilac: Gaoliang stupid, pepper, cinnamon, peony bark = 1 : 1 ·· 1 : 2 : 1 (by weight), and then crush or grind these materials, use 100 g was soaked in 100 ml (ml) of alcohol for 24 hours, and then the soaked solution was filtered through activated carbon and decolorized for later use. 0 (2) 80 g of urotropine was dissolved in 2 according to the mixing ratio. 〇〇ml of purified water for use. (3) The isothiazolinone compound is added to the ethylene glycol according to the mixing ratio and then mixed. Then, glycerin and n-hexanol are added in order, and the amount of the compound is 6 G to 4 G minutes. After the mixture is statically sealed, the dimethyl hydrazine is further added, and the stirring is continued. The plant extract of 70 ml from (1) and the mixture obtained from (2) are mixed and stirred uniformly. Set 2c to the A solution of the invention. 4 / ' ' can get this [Example 2] Preparation of A blending solution: 50ml 16〇ml 7〇ml 200ml 8〇g methyl-4-isoindole 酉 酉 酉 with ethylene glycol glycerol Alcohol urotropine 12 200822860 曱 曱 subhard 50ml plant extract 70ml clean water 200ml (1) Measured lilac: galangal · shank: cinnamon: peony = 1:1:1: X · i · i ·厶·1, from 里里,亚; i teeth open willow mash or grind, take 100 grams of soaked in 100 ml (ml) of alcohol for 24 hours, then the soaking solution through activated carbon Filter and discolor for later use. ‘, (2) 80 gram of urotropine in accordance with the mix ratio is dissolved in 2 〇〇 弁 净 clean water for use.笔αα (3) Add the isothiazoline-based compound to the second guess according to the mixing ratio, and then add glycerin and positive in order. After the addition, dimethylene was further added to 70 ml of the plant extract of (1) and obtained from (2) = the mixture was stirred and stirred, and then the mixture was added to the above-mentioned hydrazine blending solution. θ 4 hours, this can be obtained [Example 3] Preparation of A blending solution: 2-methyl-3(H)-isothiazolinone propylene glycol glycerol hexanol urotropine diterpenoids extract Purified water 30ml 120ml 80ml 220ml 80g The preparation method is the same as that in Example 1~~This ^ Cinnamon skin: Mudan peel: 2 : 1 : 2 : 8〇ml 60ml 250ml Aroma · Galangal: Shanjiao: 13 200822860 [Example 4 】 Preparation of B blending solution: 2-mercapto-3(2H)-isoproterenol 60ml Propylene glycol 150ml Glycerin 100ml Calcium 120ml Urotropine 120g Dimethylhydrazine 70ml Plant extract 120ml Purified water 180ml Modulation The method was the same as in Example 2 except that the lilac: galangal: mountain pepper: cinnamon skin: peony bark 2: 2: 1 : 2 : 1 (weight ratio). [Example 5] Preparation of A blending solution: 1,2-benzoisoindol-3-one 10 ml 2-methyl-4-isoindole- 3-indole 10 ml ethylene glycol 180 ml 120 ml 180 ml 60 g 90 ml 130ml 180ml glycerol hexanol urotropine dimethyl hydrazine plant extract clean water preparation method is the same as in the first embodiment, except lilac · galangal: mountain pepper: cinnamon skin: peony bark = 2: 3 : 1 : 2 : 4 (weight ratio). [Example 6] Preparation of B blending solution: 40 ml 25 ml 1,2-benzisoindole. Selenium-3-indole with 5-chloro-2-indolyl-4-isoindole σ-Shen-3-one 14 200822860 Ethylene glycol 90ml 125ml 250ml 110g 65ml 90ml 165ml glycerol hexanol urotropine diterpenoid plant extract clean water preparation method is the same as in example 2, except lilac · galangal · shanjiao: cinnamon : Mudanpi = 2 ·· 3 : 1 ·· 2 ·· 4 (weight ratio). [Example 7] ~ Chuan and his staff Example 1 Han Beina π 4 made the antiseptic mixture A, use the body to soak the bath ί 'dry the whole body with a towel, then, first use the left shot to extract the antiseptic mixture The sputum was 5 〇〇 well, and Jiang Wujin entered the large arterial arch. Next, the antiseptic mixture is raised/mainly. The obtained anti-corrosion wire is as shown in Table 2: ^ 2500 15 200822860 Table 2 Registration number Item 1 Example 2 Example 3 Gender male and female age 69 72 80 Body type ordinary skinny death day 2006/07/19 2006/07/28 2006 /06/25 Causes of death Cardio-cerebral vascular cancer Cardio-cerebral vascular preservation method Remains bed Remains bed Remaining bed storage temperature °0 28 28 28 Preservation humidity% 70 70 70 Facial color cyan purple yellow white blue-purple chest flat expansion abdominal abdomen slightly Green swelling edema mildly no significant corpse spots have a large area of skin peeling without odor and odorless odor (aorta) antiseptic solution A liquid 500ml A liquid 500ml A liquid 500ml (aorta) antiseptic liquid B liquid 2500ml B liquid 2500ml B Liquid 2500ml The color of the 1st face is unchanged before, the abdomen is smooth and odorless, as if the face is pale in the sleep, the abdomen is smooth and soft, odorless, as if in a sleep. The color of the face is unchanged, the abdomen is smooth and soft, and it is odorless, as if it is sleeping. No change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change No change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change, no change on the face and fingers. The skin of the whole body is completely dry and has no odor. No change No change No. 10 No change Face and fingers are dry, the skin of the whole body is completely dry and has no odor. The face is as unchanged as before, the abdomen is smooth and soft, odorless, and the skin is dry, as if in sleep. No. ‘11曰 No change No change No change No. 12曰 No change No change No change No. 13 No change No change No change No. 14 No change No change No change No. 15 颜 The face is dry. No change No change No. 16 No change No change Abdominal gas accumulation and some expansion. The 17th 曰 曰 变化 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上 上Face no change before the 21st cremation cremation cremation [schematic description] No picture [main symbol description] No 17

Claims (1)

200822860 十、申請專利範圍: 1· 一種遺體防腐混合物,該混合物係由: 容積比率 G· 15〜15%之異麵細j(isQl:hiazQline ket〇ne) 類化合物,5〜30%之二元醇,3〜20%之甘油,〇〜15%之醇, 5 5(U之正已醇,1〜15%之二曱亞硬(心肥也yi suif〇xide) 1〜18%之植物萃取物,〇〜3〇%之淨水,及重量比率〇· 1〜π% 之尼泊金酯(Nipagin 6以打)或、〜15%之烏洛托品 (urotropin)混合而構成。 2. —種遺體防腐混合物,該混合物係由: f積比率0· 15〜15%之異噻唑啉酮類化合物,5〜2〇%之二元 醇,3〜15%之甘油,5〜30%之正已醇,之二甲亞颯, 1〜18%之植物萃取物,5〜30%之淨水,及重量比率丨〜;^% 之烏洛托品混合而成。 3· —種遺體防腐混合物,該混合物係由·· 容積比率5〜8%之異噻唑琳酮類化合物,5〜2〇%之二元醇, 3〜15%之甘油’ 5〜30%之正已醇,;[〜;[〇%之二甲亞硬,1〜μ% 之植物萃取物,5〜25°/◦之淨水,及重量比率5〜15%之烏洛 托品混合而成。 ~ 4·如請求項1〜3中任一項所述之遺體防腐混合物,其中該 異嗟唑啉酮類化合物係選自:由2-曱基-4-異噻唑啦_、9 ^-3(2Η)- > 2-^-3®- ^^Γΐ, 2- 苯並異噻嗤啭-3-酮及5-氯-2-甲基-4-異嗟唾啉-3酮所構成 之群中之一種或多種化合物。 5·如請求項1〜3中任一項所述之遺體防腐混合物,其中該二 元醇係選自乙^一醇及丙一醇中之任一種或其二種混合物。 6·如請求項1〜3中任一項所述之遺體防腐混合物,其中該植 物卒取物之重篁比為紫丁香、高良薑、山椒、肉桂、牡丹皮 =(1 〜2) ·· (1 〜3) ·· (0·5〜1) ·· (2〜4) : (1 〜4)。 7· —種调製清求項1之这體防腐混合物之方法,該方法包括下 18 200822860 列步驟: (1)依預定組成比率,搗碎或磨碎植物之丁香花、高良薑、 山椒、肉桂皮、牡丹皮取得100公克之粉碎物:浸$於 ^之財經二切小時後,用活性碳過滤並脫 该次潰液以備使用; ⑵=所定配合比之烏洛托品(urotropin)溶解於淨水中以得 2由或將所定配合比之尼泊金酯(Nipagin ester)溶 於醇中以得溶液備使用; (3) 依所定配合比,將異勉侧類化合物添加於二元醇中 力;=半之二依序f甘油及正已醇加入麟混合液 :二:加以攪拌20至40分鐘,將所得 “餘暫靜置之後,添加二?亞觀續擾摔; (4) =n:製之上述⑴及⑵之準備液 ^合液中,經均勻攪拌之後,靜 體防腐混合物。 *』才向ι珉逍 8. -種對紐制防獻合物之處理方法,該方法 9二做為防腐劑施用於遺體。/ .方法係使用請求 體之處理方法,其處理;為防腐劑施用於遺 遺體之大動脈弓,注射速度為皮處理 19 200822860 七、指定代表圖: (一) 本案指定代表圖為:第( )圖。 (二) 本代表圖之元件符號簡單說明: 無圖 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式:200822860 X. Patent application scope: 1. A kind of antiseptic mixture of the body, the mixture is composed of: volume ratio G· 15~15% of the surface j (isQl:hiazQline ket〇ne) compound, 5~30% binary Alcohol, 3~20% glycerol, 〇~15% alcohol, 5 5 (U's hexanol, 1~15% bismuth subhard (heart fat also yi suif〇xide) 1~18% plant extract The composition, 〇~3〇% of purified water, and the weight ratio 〇·1~π% of parabens (Nipagin 6 to beat) or ~15% of urotropin mixed. - a preserved mixture of residues, the mixture consists of: an iso-thiazolinone compound with a ratio of 0·15 to 15%, a diol of 5 to 2%, a glycerol of 3 to 15%, and a glycerol of 5 to 30%. Alcohol, dimethyl hydrazine, 1~18% of plant extract, 5~30% pure water, and weight ratio 丨~;^% of urotropine mixed. 3·------ a mixture of the mixture of 5 to 8% by volume of isothiazolone, 5 to 2% by weight of diol, 3 to 15% of glycerol '5 to 30% of hexanol; ~;[〇% dimethyl subhard, 1~μ% The plant extract, 5 to 25 ° / 净 of purified water, and a weight ratio of 5 to 15% of urotropine are mixed. ~ 4 · The body antiseptic mixture according to any one of claims 1 to 3 Wherein the isoxazolinone compound is selected from the group consisting of: 2-mercapto-4-isothiazol-, 9^-3(2Η)- > 2-^-3®-^^Γΐ, 2- One or more compounds of the group consisting of benzisothiazol-3-one and 5-chloro-2-methyl-4-isoindolin-3-one. 5. If any of claims 1 to 3 And the diol is selected from any one of the group consisting of ethyl alcohol and propanol or a mixture thereof. 6. The method according to any one of claims 1 to 3 The antiseptic mixture of the remains, wherein the weight ratio of the plant to the residue is lilac, galangal, mountain pepper, cinnamon, and peony bark = (1 to 2) ·· (1 to 3) ·· (0·5~1) · (2~4) : (1 to 4). 7. A method of modulating the antiseptic mixture of claim 1, which comprises the following steps: 2008. Or grated plants of lilac, galangal, mountain pepper, cinnamon, and peony Get 100 grams of crushed material: dip for 2 cents of money after two cuts, filter with activated carbon and take off the crush for use; (2) = the ratio of urotropin dissolved in clean water The solution is prepared by dissolving the ratio of the Nipagin ester in the alcohol to obtain a solution; (3) adding the isoindole-type compound to the diol according to the predetermined mixing ratio; = half of the two in order f glycerol and n-hexanol added to the lining mixture: two: stir for 20 to 40 minutes, the resulting "after the temporary rest, add two? Sub-continuation disturbance; (4) =n: Preparation of the above (1) and (2) preparation liquids, after uniform stirring, static anti-corrosion mixture. * 』 向 珉逍 珉逍 - - - 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍 珉逍The method is to use the treatment method of the request body, and the treatment is performed; the preservative is applied to the aortic arch of the remains, and the injection speed is the skin treatment 19 200822860 VII. Designation representative map: (1) The designated representative figure of the case is: Figure. (2) A brief description of the symbol of the representative figure: No picture VIII. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention:
TW96112673A 2006-11-30 2007-04-11 Embalming mixture, preparation method therefor, and method of treating corpses with the embalming mixture TW200822860A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006323468A JP2008137909A (en) 2006-11-30 2006-11-30 Mixture for embalming corpse, method for preparing the same and method for applying the embalming mixture to corpse and treating the corpse therewith

Publications (1)

Publication Number Publication Date
TW200822860A true TW200822860A (en) 2008-06-01

Family

ID=39485277

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96112673A TW200822860A (en) 2006-11-30 2007-04-11 Embalming mixture, preparation method therefor, and method of treating corpses with the embalming mixture

Country Status (3)

Country Link
JP (1) JP2008137909A (en)
CN (1) CN101189962A (en)
TW (1) TW200822860A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101878755B (en) * 2010-07-06 2012-06-06 苏州博克精细化学品有限公司 Shampoo for body preservation
CN102461496B (en) * 2010-11-17 2014-10-29 民政部一零一研究所 Low-toxicity, environment-friendly short-term remains preservative and usage thereof
JP2012188365A (en) * 2011-03-09 2012-10-04 Aguri Business Ltd Preservative for dead body and method of using the same
CN104521942B (en) * 2014-12-24 2016-04-27 博兴县殡仪馆 A kind of Gentle Repose agent
CN105981716A (en) * 2015-02-03 2016-10-05 张纯清 Novel specimen preservative liquid
CN108812637A (en) * 2018-06-15 2018-11-16 河南科技大学 A kind of fur sample environment-friendly type ointment preservative and preparation method thereof
JP7283180B2 (en) 2019-03-29 2023-05-30 住友大阪セメント株式会社 optical modulator
CN110720452B (en) * 2019-11-05 2021-11-19 南通大学 Method for optimizing preservation of pathological gross specimens

Also Published As

Publication number Publication date
JP2008137909A (en) 2008-06-19
CN101189962A (en) 2008-06-04

Similar Documents

Publication Publication Date Title
TW200822860A (en) Embalming mixture, preparation method therefor, and method of treating corpses with the embalming mixture
CN102461496B (en) Low-toxicity, environment-friendly short-term remains preservative and usage thereof
CN104094923B (en) A kind of antiseptic preserving fluid for corpse, tissue and dissection and using method thereof
CN104540532A (en) Composition containing ecotine or hydroxyecotine as an active substances for promoting the regeneration of injured body tissue
TW201142033A (en) Bacterial cellulose film, and use thereof
EP3918915A1 (en) Functional water
JP2022121673A (en) Auxiliary solvent for bio-introduction and method of using the same
JP2006089462A (en) Synthetic product for embalming corpse for long period, method for producing the same, and method for applying the embalming synthetic product to the corpse and treating the corpse therewith
US11273114B2 (en) Compound additive having biological activation function, preparation method therefor and use thereof
Sunkara et al. An essential role for polyamines in tumor metastases
TW200816917A (en) Anticorrosive compound for body remains and the preparation method and application of the same
CN101489528B (en) Cell-activating agent, collagen production-promoting agent, bleaching agent, anti-oxidizing agent, anti-inflammatory agent, aromatase activity-promoting agent, protease activity-promoting agent, skin topical agent and food
TW201249444A (en) Antitumor medicine comprising carbon dioxide as an active ingredient
CN105963243B (en) A kind of borneol cinnamomum camphora essential oil sustained release emulsifiable paste and preparation method thereof for treating acne vulgaris
CN106232101A (en) The cosmetic composition of Herba Menthae vinegar is contained as effective ingredient
WO2009122056A1 (en) Composition for tissue preservation
CN108653247A (en) It is a kind of to have the defervescence plaster used preparation method for absorbing effect of bringing down a fever
HU186767B (en) Process for producing compositions for treating dermatologicalanomalys
JP2011132131A (en) Cosmetic liquid and method for producing cosmetic liquid
CN107349189B (en) A kind of sorbierite mannitol flushing liquor suitable for urological surgery
CN102405293A (en) Membrane of biological fibers, and use thereof
JP2839778B2 (en) Bathing agent utilizing the effect of essential oil components in Senseki extract on permeation of drug through skin
CN109528754A (en) Composition, externally applied drug, preparation method and its application for treating the externally applied drug of inner cavity mucosal inflammation
CN101559047A (en) Function of xylitol erythritol in wound irrigation
CN108159170A (en) Piece and preparation method and application is released for the freeze-drying sudden strain of a muscle of local skin anesthesia